Multiple sclerosis trials in Sweden
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Where
- Huddinge
- Age
- 18 years to 60 years
- People
- 705 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00 - Phase 3Taking peopleA Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Where
- Huddinge, Stockholm, Stockholm
- Age
- 18 years to 60 years
- People
- 990 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00 - Phase 2Taking peopleThe HIt HArd and hiT Early in Multiple Sclerosis Trial
- Where
- Falun, Gavle, Karlstad, Uppsala
- Age
- 18 years to 50 years
- People
- 60
- Run by
- Uppsala University
See details and how to joinNCT07517185 · EU 2024-519700-28-01 - Phase 3Taking peopleA Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
- Where
- Goteborg
- Age
- 18 years to 64 years
- People
- 125 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-512914-16-00 · EU 2024-512914-16-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Gothenburg, Stockholm
- Age
- 18 years to 65 years
- People
- 1,275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - Phase 3Taking peopleNon-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Where
- Goteborg, Huddinge, Malmo, Stockholm
- Age
- 18 years to 60 years
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT07325292 · EU 2026-525688-41-00 - No phaseTaking peopleThe EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
- Where
- Bergshamra
- Age
- 2 years and over
- People
- 200
- Run by
- Otto Bock Healthcare Products GmbH
See details and how to joinNCT05901259 - Phase 3Taking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Goteborg, Huddinge
- Age
- 18 years and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00 - Phase 3Taking peopleA Randomized Open Label Trial Exploring the Soluble and Imaging Biomarker Dynamic Responses to Tolebrutinib Compared to Rituximab Treatment in Patients with Multiple Sclerosis (MS)
- Where
- Stockholm
- Age
- 18 years and over
- People
- 60
- Run by
- Region Stockholm – SLSO
See details and how to join2025-523892-50-00 · EU 2025-523892-50-00 - No phaseTaking peopleRemote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
- Where
- Umeå
- Age
- 18 years and over
- People
- 350
- Run by
- Umeå University
See details and how to joinNCT05819008 - No phaseTaking peopleImproving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis - A Feasability Study
- Where
- Gävle
- Age
- 18 years to 65 years
- People
- 20
- Run by
- Region Gävleborg
See details and how to joinNCT07380295 - No phaseNot yet taking people in SwedenImmune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy
- Where
- Stockholm
- Age
- 18 years and over
- People
- 111
- Run by
- Region Stockholm
See details and how to joinNCT07149662 - No phaseNot yet taking people in SwedenRelationship Between Cognition, Workforce Participation and Well-Being in Individuals With Multiple Sclerosis
- Where
- Gävle
- Age
- 18 years to 65 years
- People
- 75
- Run by
- Region Gävleborg
See details and how to joinNCT07211516 - No phaseNot yet taking people in SwedenEvaluation of the Wheelchair School (Drivkraft) a Clinical Study
- Where
- Solna
- Age
- 18 years and over
- People
- 80
- Run by
- Karolinska Institutet
See details and how to joinNCT07131553 - No phaseTaking peopleMotor-cognitive Performance in People With Multiple Sclerosis
- Where
- Stockholm
- Age
- 18 years to 65 years
- People
- 90
- Run by
- Karolinska Institutet
See details and how to joinNCT06312046 - No phaseEnrolling by invitationInternet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments
- Where
- Stockholm
- Age
- 18 years and over
- People
- 64
- Run by
- Aniko Bartfai
See details and how to joinNCT06973018